Cargando…
A slow-cycling Lgr5 tumour population mediates basal cell carcinoma relapse after therapy
Basal cell carcinoma (BCC) is the most frequent cancer in humans and results from constitutive activation of the Hedgehog pathway1. Several Smoothened inhibitors (Smoi) are used to treat Hedgehog-mediated malignancies, including BCC and medulloblastoma2. Vismodegib, a Smoi, leads to BCC shrinkage in...
Autores principales: | Sánchez-Danés, Adriana, Larsimont, Jean-Christophe, Liagre, Mélanie, Muñoz-Couselo, Eva, Lapouge, Gaëlle, Brisebarre, Audrey, Dubois, Christine, Suppa, Mariano, Sukumaran, Vijayakumar, del Marmol, Véronique, Tabernero, Josep, Blanpain, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295195/ https://www.ncbi.nlm.nih.gov/pubmed/30297799 http://dx.doi.org/10.1038/s41586-018-0603-3 |
Ejemplares similares
-
Defining the clonal dynamics leading to mouse skin tumour initiation
por: Sánchez-Danés, Adriana, et al.
Publicado: (2016) -
Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease
por: Benhadou, Farida, et al.
Publicado: (2020) -
Single stem cell gene therapy for genetic skin disease
por: Larsimont, Jean-Christophe, et al.
Publicado: (2015) -
Where Artificial Intelligence Can Take Us in the Management and Understanding of Cancerization Fields
por: Orte Cano, Carmen, et al.
Publicado: (2023) -
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature
por: Casagranda, Aneline, et al.
Publicado: (2017)